Review
doi: 10.1159/000199835.
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature
Affiliations
- PMID: 2548911
- DOI: 10.1159/000199835
Item in Clipboard
Review
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature
Digestion.
1989.
Abstract
We report 1 patient with a necrolytic migratory erythema, a high plasma glucagon concentration and a metastatic pancreatic endocrine tumor who has now been treated effectively for 33 months with the somatostatin analogue octreotide (SMS 201-995) (400 micrograms/day). The results of SMS 201-995 in the treatment of glucagonoma syndrome are reviewed.
Similar articles
-
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.Surgery. 1986 Dec;100(6):989-96. Surgery. 1986. PMID: 2878500
-
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.N Engl J Med. 1986 Jun 26;314(26):1686-9. doi: 10.1056/NEJM198606263142606. N Engl J Med. 1986. PMID: 2872592 No abstract available.
-
Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.J Surg Oncol. 1990 Jul;44(3):191-9. doi: 10.1002/jso.2930440313. J Surg Oncol. 1990. PMID: 2164620
-
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.Dig Dis Sci. 1989 Mar;34(3 Suppl):28S-39S. doi: 10.1007/BF01536043. Dig Dis Sci. 1989. PMID: 2537716 Review.
-
The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.Horm Res. 1988;29(5-6):211-3. doi: 10.1159/000181005. Horm Res. 1988. PMID: 2851522 Review.
Cited by
-
Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.Med Oncol. 2007;24(3):330-7. doi: 10.1007/s12032-007-0011-2. Med Oncol. 2007. PMID: 17873310
-
The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.Clin Investig. 1994 Jan;72(2):127-33. doi: 10.1007/BF00184589. Clin Investig. 1994. PMID: 8186658
-
Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.Endocrine. 2003 Apr;20(3):285-90. doi: 10.1385/ENDO:20:3:285. Endocrine. 2003. PMID: 12721509 Review.
-
Necrolytic migratory erythema associated with glucagonoma: a report of 2 cases.Clinics (Sao Paulo). 2008 Apr;63(2):267-70. doi: 10.1590/s1807-59322008000200016. Clinics (Sao Paulo). 2008. PMID: 18438582 Free PMC article. No abstract available.
-
[The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].Chirurg. 2006 Jun;77(6):535-8. doi: 10.1007/s00104-005-1122-y. Chirurg. 2006. PMID: 16362349 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
